Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
OTC
Return to: PBR Home | Production & Manufacturing | OTC

OTC

Valeant to divest iNova Pharmaceuticals for $930m By PBR Staff Writer
Valeant Pharmaceuticals International has agreed to divest its iNova Pharmaceuticals business for around $930m.
Production & Manufacturing > OTC > News
Fresenius Kabi agrees to acquire Akorn for $4.3bn By PBR Staff Writer
German healthcare firm Fresenius Kabi has agreed to acquire US prescription and over-the-counter (OTC) pharmaceutical products manufacturer Akorn for around $4.3bn.
Production & Manufacturing > OTC > News Sanofi agrees to divest five OTC products to Ipsen for EUR83m By PBR Staff Writer
Sanofi has agreed to divest five of its over-the-counter consumer healthcare products in Europe to French pharma firm Ipsen for €83m.
Production & Manufacturing > OTC > News
See more OTC news

Latest OTC News and Insight

View all OTC news or find news targeted to your interests
Sanofi agrees to divest five OTC products to Ipsen for EUR83m
By PBR Staff Writer
Sanofi has agreed to divest five of its over-the-counter consumer healthcare products in Europe to French pharma firm Ipsen for €83m.
Production & Manufacturing > OTC > News
GSK Consumer Healthcare launches new OTC allergy relief product in US
GSK Consumer Healthcare has launched a new over-the-counter (OTC) treatment for symptoms associated with seasonal and perennial allergies, branded as Flonase Sensimis Allergy Relief (fluticasone furoate, 27.5 mcg spray) in the US.
Production & Manufacturing > OTC > News
Reckitt Benckiser in talks to acquire Mead Johnson for $16.7bn
By PBR Staff Writer
British consumer goods maker Reckitt Benckiser is in advance negotiations to acquire tye US infant formula manufacturer Mead Johnson Nutrition for $16.7bn.
Production & Manufacturing > OTC > News
FDA approves Sanofi's Xyzal Allergy 24HR for OTC use
By PBR Staff Writer
Sanofi has secured approval from the US Food and Drug Administration (FDA) for its 24-hour formulation of levocetirizine dihydrochloride (Xyzal Allergy 24HR) for the over-the-counter (OTC) treatment of symptoms associated with seasonal and year-round allergies.
Production & Manufacturing > OTC > News
Valeant Pharmaceuticals agrees to divest $2.1bn in assets
By PBR Staff Writer
Valeant Pharmaceuticals International has agreed to sell about $2.1bn in assets as it seeks to reduce over $30bn in debt.
Production & Manufacturing > OTC > News
FDA approves Perrigo's generic Nicorette White Ice Mint Gum
Perrigo has secured approvals from the US Food and Drug Administration for abbreviated new drug applications referencing GlaxoSmithKline's Nicorette White Ice Mint Gum (nicotine polacrilex gum 2 mg and 4 mg).
Production & Manufacturing > OTC > News
Perrigo plans to restructure Branded Consumer Healthcare's Belgium business
Perrigo is planning to restructure its Omega Pharma Belgium business to improve the financial profile and focus on branded consumer over-the-counter (OTC) products.
Production & Manufacturing > OTC > News
View all OTC news or find news targeted to your interests